Koyfin Home > Directory > Health Care > Aduro Biotech > EV / EBITDA (ntm)

Aduro Biotech EV / EBITDA (ntm) Chart (ADRO)

Aduro Biotech annual/quarterly EV / EBITDA (ntm) from 2015 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Aduro Biotech EV / EBITDA (ntm) for the quarter ending March 03, 2020 was 0.00 a -92,543.79% decrease of -0.93 year over year
  • Aduro Biotech EV / EBITDA (ntm) for the last 12 months ending March 03, 2020 was 0.00 a -92,543.79% decrease of -0.93 year over year
  • Aduro Biotech Annual EV / EBITDA (ntm) for 2020 was 0.00 a -21,869.95% decrease of -0.22 from 2019
  • Aduro Biotech Annual EV / EBITDA (ntm) for 2020 was 0.22 a -352.56% decrease of -0.78 from 2019
  • Aduro Biotech Annual EV / EBITDA (ntm) for 2019 was 1.00 a 6.82% increase of 0.07 from 2018
Other Valuation Metrics:
  • Aduro Biotech Market Cap for the quarter ending March 03, 2018 was $753m a -5.79% decrease of -44m year over year
  • Aduro Biotech Price / Book for the quarter ending March 03, 2018 was 3.04 a -14.05% decrease of -0.43 year over year
  • Aduro Biotech Enterprise Value for the quarter ending March 03, 2018 was $427m a -3.70% decrease of -16m year over year
View Chart On Koyfin

Quarterly ADRO EV / EBITDA (ntm) Data

03/20200.00
03/20200.22
06/20191.00
06/20190.93
06/20190.84
06/20190.82
02/20190.07
01/20190.28
01/20190.49
01/20190.68

Annual ADRO EV / EBITDA (ntm) Data

20200.00
20200.22
20191.00
20190.93
20190.84
20190.82
20190.07
20190.28
20190.49
20190.68